RNS Number:0279M
Keryx Biopharmaceuticals Inc
06 June 2003

Keryx Biopharmaceuticals, Inc ("the Company")



The Company was notified yesterday that on the 4 June 2003 Michael S. Weiss
bought 5,000 shares of Keryx common stock.


The shares were purchased in two tranches, 2,500 shares @ $1.7478 per share and
2,500 shares @ $1.7620 per share. His resultant beneficial holding is 5,000
shares.


6 June 2003


Contact:

Mr Bob Trachtenberg

General Counsel, Keryx Biopharmaceuticals, Inc.

Tel: 00 972 2541 3500



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSXQLFBXQBLBBB